MPO and atherosclerosis: The detection of increased levels of the HOCl-specific marker, 3-chlorotyrosine, in LDL isolated from human lesions [17, 18], together with evidence for the presence of MPO-LDL complexes in the circulation of patients with atherosclerosis [19], support MPO as a pathway to LDL modification in vivo.